PF 03882845

· Pfizer

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for PF 03882845, covering 2009-12-23 to 2013-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy [Phase 1]

See pricing